Design, Synthesis, and Antibacterial Evaluation of Novel Ocotillol Derivatives and Their Synergistic Effects with Conventional Antibiotics.

Design, Synthesis, and Antibacterial Evaluation of Novel Ocotillol Derivatives and Their Synergistic Effects with Conventional Antibiotics.
复制标题

新型奥克替醇衍生物的设计、合成、抗菌评价及其与常规抗生素的协同作用

DOI:
10.3390/molecules26195969
复制
发表时间:
2021-10-01
期刊:
Molecules (Basel, Switzerland)
影响因子:
--
通讯作者:
Bi Y
Bi Y
中科院分区:
其他
文献类型:
--
作者:
Zhang D;Cao Y;Wang K;Shi Z;Wang R;Meng Q;Bi Y

文献摘要

参考文献

相似文献

抗生素使用不当导致细菌产生耐药性,导致许多细菌感染的抗生素减少。尤其是医院获得性耐甲氧西林金黄色葡萄球菌(HA-MRSA)的耐药性尤为严重。本研究设计并合成了两个系列的3-取代奥克替醇衍生物,以提高其抗HA-MRSA的效力和协同抗菌活性。在合成的化合物中,20-31 种在体外对 HA-MRSA 18-19、18-20 和金黄色葡萄球菌 ATCC29213 的最低抑制浓度 (MIC) 值为 1-64 µg/mL。化合物21的抗菌活性最好,MIC为1μg/mL,具有协同抑制作用。当与氯霉素(CHL)或卡那霉素(KAN)组合时,分数抑制浓度指数(FICI)值为0.375。还总结了奥克替洛尔型衍生物的构效关系(SAR)。化合物21有潜力被开发为新型抗菌剂或针对HA-MRSA的增强剂。
The improper use of antibiotics has led to the development of bacterial resistance, resulting in fewer antibiotics for many bacterial infections. Especially, the drug resistance of hospital-acquired methicillin-resistant Staphylococcus aureus (HA-MRSA) is distinctly serious. This research designed and synthesized two series of 3-substituted ocotillol derivatives in order to improve their anti-HA-MRSA potency and synergistic antibacterial activity. Among the synthesized compounds, 20–31 showed minimum inhibitory concentration (MIC) values of 1–64 µg/mL in vitro against HA-MRSA 18–19, 18–20, and S. aureus ATCC29213. Compound 21 showed the best antibacterial activity, with an MIC of 1 μg/mL and had synergistic inhibitory effects. The fractional inhibitory concentration index (FICI) value was 0.375, when combined with chloramphenicol (CHL) or kanamycin (KAN). The structure–activity relationships (SARs) of ocotillol-type derivatives were also summarized. Compound 21 has the potential to be developed as a novel antibacterial agent or potentiator against HA-MRSA.
DOI: 10.1016/j.micpath.2017.08.012
发表时间: 2017-10-01
影响因子: 3.8
作者:
Oloyede, H. O. B.;Ajiboye, H. O.;Ajiboye, T. O.
通讯作者: Ajiboye, T. O.
DOI: 10.1016/j.jgr.2016.08.004
发表时间: 2017-10
影响因子: 6.3
作者:
Kim JH;Yi YS;Kim MY;Cho JY
通讯作者: Cho JY
奥克替醇型皂苷的发现、半合成、生物活性和代谢
DOI: 10.1016/j.jgr.2017.01.001
发表时间: 2017-07
影响因子: 6.3
作者:
Liu J;Xu Y;Yang J;Wang W;Zhang J;Zhang R;Meng Q
通讯作者: Meng Q
DOI: 10.1016/j.tetlet.2008.04.090
发表时间: 2008-06-16
影响因子: 1.8
作者:
Lin, Geng-Jie;Luo, Shi-Peng;Huang, Pei-Qiang
通讯作者: Huang, Pei-Qiang
DOI: 10.1111/cbdd.12337
发表时间: 2014-10-01
影响因子: 3
作者:
Bi, Yi;Ma, Cong;Xu, Jinyi
通讯作者: Xu, Jinyi